Reducing alcohol-related crashes among young adult drivers
Modeling a national Graduated-BAC per se policy for 21-24 y/o drivers to reduce alcohol impaired driving injury and fatal crashes
This study is looking at how changing the legal blood alcohol limit for drivers aged 21 to 24 might help reduce drunk driving accidents and keep young people safer on the roads.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11163889 on NIH RePORTER |
What this research studies
This research investigates the impact of implementing a graduated blood alcohol content (BAC) policy for drivers aged 21 to 24 years to reduce alcohol-impaired driving incidents. It aims to model how adjusting the legal BAC limit can potentially lower the rates of serious injuries and fatalities among young drivers. The study will analyze data on alcohol consumption, driving behaviors, and crash statistics to inform policy recommendations. By focusing on this vulnerable age group, the research seeks to enhance public safety and reduce the societal costs associated with alcohol-related crashes.
Who could benefit from this research
Good fit: Ideal candidates for this research are young adults aged 21 to 24 who drive and consume alcohol.
Not a fit: Patients who are not within the age range of 21 to 24 or do not engage in driving may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant reductions in alcohol-related injuries and fatalities among young adult drivers.
How similar studies have performed: Previous research has shown that lower BAC limits for younger drivers can effectively reduce crash rates, indicating that this approach has potential for success.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Vaca, Federico E — University of California-Irvine
- Study coordinator: Vaca, Federico E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.